ASNDAscendis Pharma A/SUptrend

TodayUptrendcalm stock

Nasdaq GSBiotechnologyMarket cap $16.13B

245.15+0.73% todayClose of Oct 26, 2026 · end-of-day snapshot

Not sure what's inside? Read a full TSLA analysis, currently free

Figures as of Oct 26, 2026Unlock all 8$9.90one-time

AI summary

The ASND read, in plain language

The AI summary distills ASND's accumulation, technical and fundamental reads into a few plain-language sentences, generated fresh after you unlock.

In the full analysis:

Full narrative & key driversLocked
Technicals readLocked
Fundamentals readLocked
Accumulation readLocked
Risks with evidenceLocked
Market context readLocked

Unlock ASND: AI summary

Technical readingsFree

Uptrend, extendedSee the full setup read: unlock ASND

Trend state Uptrend, stage 2 of 4, 1 of 4 damage flags raised (as of Oct 26, 2026)

Automated read

Price is trading above its key moving averages, but momentum readings are in extended territory: the mid-term picture reads as a stretched uptrend. RSI is currently 61.

Readings, end-of-day Oct 26, 2026

RSI (14)Upper-neutral61.02

MACD / signalAbove signal line0.27 / -2.84

SMA 50Price above242.53

SMA 200Price above237.32

EMA 20Price above234.82

ADX (14)Trending27.87

Show all 12 readings

+DI / −DI+DI leading27.69 / 17.32

ATR (14)2.5% of price — typical daily swing6.13

Stochastic %KOverbought zone95.35

Bollinger bands (20)Above upper band: stretched216.97 – 243.96

ROC (10)Positive over 10 sessions8.00

Trend / momentum impulseTrend and momentum agreeBoth rising

How different investors read thisNo verdict. Ever.

Long-term holder

Add or trim?

Short-term trader

Enter or wait?

Not yet invested

Start or skip?

Looking ahead

What has to go right?

Each horizon shown is argued both ways; unlocking shows the points behind both sides.

Evidence from this report, not a recommendation.

Unlock ASND: the full evidence

Full analysis

What unlocking ASND reveals

Short term · weeksMomentum extendedMid term · monthsUptrend, extendedLong term · business qualityStrongMarket linkshows little relationship with the S&P 500

These classifications are computed from ASND's live data. The detail behind them is what unlocks.

Company & theme write-upWhat the company does, the themes it belongs to, and the tags that place it beside its peers.Generated on unlock

Signals & levelsSignals computed from this stock's own price bands, each naming the sessions behind it.

Signal history16 volume signals in the past year; the median 3-month move after them was +8.80%, positive 13 of 16 times.

AI narrativeThe volume, technical and fundamental reads tied into one plain-language story.Generated on unlock

Catalysts & risksScheduled events set beside the risks the narrative flags, each paired to its figure.Generated on unlock

Fundamentals & valuationThe fundamentals read strong; the full table shows every input.

Market context & correlationsShows little relationship with the S&P 500; the full table names each instrument and window.

Accumulation readVolume measured against this stock's own baseline, broken down day by day.Generated on unlock

Generated on unlock: written when ASND's analysis runs, rather than checked against its stored data now.

Company & theme write-upWhat the company does, the themes it belongs to, and the tags that place it beside its peers.Generated on unlock

Signal historyEvery past volume signal measured forward from the day it fired.Generated on unlock

AI narrativeThe volume, technical and fundamental reads tied into one plain-language story.Generated on unlock

Catalysts & risksScheduled events set beside the risks the narrative flags, each paired to its figure.Generated on unlock

Accumulation readVolume measured against this stock's own baseline, broken down day by day.Generated on unlock

Generated on unlock: written when ASND's analysis runs, rather than checked against its stored data now.

Every section above, argued on ASND's own numbers, on one page.

See what ASND costs Not sure what's inside? Read a full TSLA analysis, currently free

Unlock the full ASND analysis

AI narrative, signals and history, social sentiment and the full fundamentals, refreshed each market day for 30 days.

Unlocked in about 60 seconds
No account needed
Secure checkout via Stripe

Covering a bigger list? Get 15 for $49.00: one-time, 30 days for the whole pack, swaps included.

Free weekly sample report

Get a full sample stock analysis in your inbox every week, no card, just the same read you see here on one hand-picked ticker.

Need the raw data?Get ASND + ~23,000 stocks as a clean CSV: every column, ready to load into a spreadsheet or notebook.

Build a dataset

Not investment advice. Everything on this page is descriptive market data and automated analysis provided for information only. It is not a recommendation, offer, or solicitation to buy or sell any security, and it does not account for your personal circumstances. Figures are from an end-of-day snapshot and may be delayed or restated; always verify against a primary source before acting. You are solely responsible for your own decisions.

About the signals.Buy and sell signals on this page are computed automatically from this stock’s own past price history: they summarise what happened after similar sessions, over the window each signal states. They are measurements of the past, not predictions, forecasts, or targets, and past behaviour does not determine future results. A signal is never a suggestion that you take any action.

Data dictionary

$9.90one-time Unlock ASND

The ASND read, in plain language

Technical readingsFree

How different investors read thisNo verdict. Ever.

Long-term holder

Short-term trader

Not yet invested

Looking ahead

What unlocking ASND reveals

Unlock the full ASND analysis

More Healthcare stocks

Put ASND next to a peer

How different investors read thisNo verdict. Ever.

Long-term holder

Short-term trader

Not yet invested

Looking ahead

The ASND read, in plain language